Rapid hepatic clearance of 99mTc-TMEOP: A new candidate for myocardial perfusion imaging

Contrast Media and Molecular Imaging

Volumn 6, Issue 4, 2011, Pages 178-188

  Goethals, Lode R ^a,b   Santos, Isabel ^c   Caveliers, Vicky ^a,b   Paulo, Antonio ^c   De Geeter, Frank ^b   Lurdes, Patrício G ^c   Fernandes, Célia ^c   Lahoutte, Tony ^a,b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

Author keywords

Heart liver ratio, biodistribution; Myocardial perfusion imaging; Small animal; Tracer development

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OCTANOL; TECHNETIUM 99M; TECHNETIUM TRI METHOXY TRIS PYRAZOLYL 99M; TETROFOSMIN; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG UPTAKE; HEART; IMAGE ANALYSIS; IN VIVO STUDY; KIDNEY; LIVER; LIVER CLEARANCE; LUNG; MALE; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RADIOCHEMISTRY; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIVER; MALE; MYOCARDIAL PERFUSION IMAGING; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80051945093     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.413     Document Type: Article

References (46)

1. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 1991; 21: 173-181.
2. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-227.
3. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
4. Parker JA. Cardiac nuclear medicine in monitoring patients with coronary heart disease. Semin Nucl Med 2001; 31: 223-237.
5. Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarritt PH, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med 2002; 29: 1608-1616.
6. Kailasnath P, Sinusas AJ. Comparison of Tl-201 with Tc-99m labeled myocardial perfusion agents: technical, physiological, and clinic issues. J Nucl Cardiol 2001; 8: 482-498.
7. Llaurado JG. The quest for the perfect myocardial perfusion indicator. still a long way to go. J Nucl Med 2001; 42: 282-284.
8. Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 1994; 35: 356-359.
9. Nuyts J, Dupont P, Van den Maegdenbergh V, Vleugels S, Suetens P, Mortelmans L. Study of the liver-heart artifact in emission tomography. J Nucl Med 1995; 36: 133-139.
10. Heller GVTracer selection with different stress modalities based on tracer kinetics. J Nucl Cardiol 1996; 5: S15-S21.
11. Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial Tc-99m tetrofosmin uptake during adenosine induced vasodilatation with either a critical or mild coronary stenosis. Comparison with Tl-201 and regional myocardial blood flow. Circulation 1997; 96: 2332-2338.
12. Watson DD, Glover DK. Overview of kinetics and modelling. In Nuclear Cardiology: State of the Art and Future Directions, Zaret BL, Beller GA (eds). Mosby: St Louis, MO, 1993; 3-12.
13. Shanoudy H, Raggi P, Beller GA, et al. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease. J Am Coll Cardiol 1998; 31: 331-337.
14. Higley B, Smith FW, Smith T, et al. Techetium-99m-1, 2[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-38.
15. Banerjee S, Pillai MRA, Ramamoorthy N. Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med 2001; 31: 260-277.
16. Boz A, Gungor F, Karayalcin B, Yildiz A. The effects of solid food in prevention of intestinal activity in Tc-99m tetrofosmin myocardial perfusion scintigraphy. J Nucl Cardiol 2003; 10: 161-167.
17. van Dongen AJ, van Rijk PP. Minimizing liver, bowel, and gastric activity in myocardial perfusion SPECT. J Nucl Med 2000; 41: 1315-1317.
18. Hurwitz GA, Clark EM, Slomka PJ, Siddiq SK. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with Tc-99m sestamibi. Clin Nucl Med 1993; 18: 735-741.
19. Boz A, Karayalcin B. Which is better for inferior wall evaluation: a full or empty stomach? J Nucl Med 1996; 37: 1916-1917.
20. Hatada K, Riou LM, Ruiz M, et al. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. J Nucl Med 2004; 45: 2095-2101.
21. Liu S, He ZJ, Hsieh WY, Kim YS. Evaluation of novel cationic 99mTc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups. Nucl Med Biol 2006; 33: 419-432.
22. Kim YS, Wang J, Broisat A, Glover DK, Liu S. Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging. J Nucl Cardiol 2008; 15: 535-546.
23. Pasqualini R, Duatti A, Bellande E, et al. Bis (dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: a class of neutral myocardial imaging agents. J Nucl Med 1994; 35: 334-341.
24. Fagret D, Ghezzi C, Vanzetto G. 99mTc-N-NOET imaging for myocardial perfusion: can it offer more than we already have? J Nucl Med 2001; 42: 1395-1396.
25. Leppo JA, DePuey EG, Johnson LL. A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991; 32: 2012-2022.
26. Maria L, Cunha S, Videira M, et al. Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents. Dalton Trans 2007; 3010-3019.
27. Maria L, Fernandes C, Garcia R, et al. Tris(pyrazolyl)methane 99mTc tricarbonyl complexes for myocardial imaging. Dalton Trans 2009; 603-606.
28. 99mTc with a multidentate amine oxime. Int J Appl Radiat Isot 1984; 35: 467-470.
29. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imag 2003; 2: 131-137.
30. Vanhove C, et al. Interest of the ordered subsets expectation maximization (OS-EM) algorithm in pinhole single-photon emission tomography reconstruction: a phantom study. Eur J Nucl Med 2000; 27: 140-146.
31. Vanhove C, et al. Reconstruction of gated myocardial perfusion SPET incorporating temporal information during iterative reconstruction. Eur J Nucl Med Mol Imag 2002; 29: 465-472.
32. Ficaro EP, Lee BC, Kritzman JN, Corbett JR. Corridor 4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol 2007; 14: 455-465.
33. 99mTc complexes useful as radiopharmaceuticals for heart imaging. Dalton Trans 2007; 1183-1193.
34. Kim YS, He ZJ, Hseh WY, Liu S. Synthesis, characterization and X ray crystal structure of [Re(PNP)(CO)3]Br-2CH3OH: model compound for a new class of cationic 99mTc radiotracers. Inorg Chem Acta 2006; 359: 2479-2488.
35. Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of Technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1522.
36. Marmion ME, Woulfe SR, Neumann WL, Nosco DL, Deutsch E. Preparation and characterization of technetium complexes with Schiff-base and phosphine coordination. 1. Complexes of technetium-99g and -99m with acac2en and trialkyl phosphines (where acac2en=N, N'-ethylenebis[acetylacetone iminato]). Nucl Med Biol 1999; 26: 755-770.
37. Deutsch E, Ketring AR, Libson K, Vanderheyden J, Hirth WW. The Noah's ark experiment: Species dependent biodistributions of cationic 99mTc complexes. Nucl Med Biol 1989; 16: 191-232.
38. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetiumtetrofosmin. I: uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995; 2: 317-326.
39. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995; 2: 327-333.
40. Bolzati C, Uccelli L, Boschi A, et al. Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake. Nucl Med Biol 2000; 27: 369-374.
41. Piwnica-Worms D, Kronauge FP, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1832.
42. Duchen MR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Asp Med 2004; 25: 365-451.
43. Kim YS, Shi J, Zhai S, Hou G, Liu S. Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: a new perfusion radiotracer for heart imaging. J Nucl Cardiol 2009; 16: 571-579.
44. Liu S, He ZJ, Hsieh WY, Kim YS. Impact of bidentate cheators on lipophilicity, stability and biodistribution characteristics of cationic 99mTc-nitrido complexes. Bioconj Chem 2007; 18: 929-936.
45. Hendel RC, Jamil T, Glover DK. Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol 2003; 2: 197-204.
46. Esteves FP, Raggi P, Folks RD, et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol 2009; 16: 927-934.